Novo Nordisk, the Danish pharmaceutical giant behind the obesity drug Wegovy, said on Wednesday it will cut about 9,000 jobs globally in a major restructuring effort, aiming to save 8 billion Danish crowns ($1.26 billion) annually. The move underscores the growing pressure the company faces from its US rival Eli…
The Ocado share price continued its strong downward trend, turning one of the top UK companies into a fallen…
Holiday sales in the United States are set to increase at the slowest pace since the pandemic, according to…
The European Commission is weighing restrictions on social media access for children under 16, aligning with growing international scrutiny…
3iQ Corp. (“3iQ”), a global provider of digital asset investment solutions, announced that the 3iQ Solana Staking ETF (TSX:…
Gold and crude oil prices extended gains on Wednesday, with copper prices remaining largely unchanged from the previous close. Silver…
A day of stunning political drama is sending shockwaves through Asian markets, creating a dramatic and powerful divergence. In…
A day of high drama is underway across the globe, as the French government collapses after a dramatic no-confidence…
Beneath the surface of seemingly unified decisions, significant fault lines are widening within the OPEC+ alliance, as revealed by…